Core Viewpoint - The company, Guolv Cultural Investment Group Co., Ltd., is undergoing a restructuring process involving the acquisition of 100% equity in Runtian Industrial from Jiangxi Maitong Health Beverage Development Co., Ltd. and two other parties through a combination of share issuance and cash payment, along with raising supporting funds [1][2]. Group 1: Performance and Commitment - Since Jiangxi Tourism Group became the controlling shareholder, Guolv has faced issues with performance commitments from historical acquisitions, particularly with Yihui Investment regarding Beijing New Line Zhongshi Cultural Communication Co., Ltd., which failed to meet profit commitments for 2020 and 2022, resulting in compensation obligations totaling 37.004 million yuan [2][4]. - The independent financial advisor confirmed that aside from the mentioned performance compensation issues, all other commitments made by Guolv and related parties have been fulfilled or are in progress, with no irregularities noted [4][10]. Group 2: Compliance and Regulatory Issues - Over the past three years, Guolv has not engaged in any violations regarding fund occupation or external guarantees, and there have been no significant administrative or criminal penalties against the company or its key personnel [5][10]. - The company has faced regulatory warnings from the Shanghai Stock Exchange and the China Securities Regulatory Commission due to accounting errors and late disclosures, but these do not constitute major penalties [9][10]. Group 3: Financial Performance and Accounting Practices - The company reported significant losses over the past three years, with net profits of -6.61357 million yuan in 2024, -1.830 million yuan in 2023, and -146.86 million yuan in 2022, indicating a downward trend in financial performance [14][15]. - The independent financial advisor found no evidence of false transactions or profit manipulation, and all accounting practices adhered to the relevant standards, with no significant changes or errors that would indicate a "big bath" accounting strategy [16][18]. Group 4: Asset Evaluation and Transaction Details - The current transaction does not involve the disposal of assets, as it is focused on acquiring Runtian Industrial through share issuance and cash payment [19].

证券代码：600728 证券简称：佳都科技 公告编号：2025-069 佳都科技集团股份有限公司 第十一届董事会第二次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 佳都科技集团股份有限公司（以下简称"公司"）第十一届董事会第二次会 议通知于 2025 年 8 月 12 日以电子邮件、短信等方式通知到各位董事。会议于 事长陈娇女士主持，董事刘伟、GU QINGYANG（顾清扬）、刘佳、张利连，独 立董事刘娥平、韩宝明、王涛出席了会议。参加本次会议的董事超过全体董事的 半数，符合《中华人民共和国公司法》及《佳都科技集团股份有限公司章程》的 有关规定，会议经审议通过了以下议案： 董事会认为，公司依据实际情况计提资产减值准备，符合《企业会计准则》 和公司相关制度的规定，公允地反映了公司的资产状况，同意本次计提资产减值 准备。 一、2025 年半年度报告及摘要 本议案提交董事会审议前已经董事会审计委员会审议通过。具体内容详见公 司同日在上海证券交易所网站（www.sse.com.cn）披露的相关公告。 具体内容详见 ...

Core Viewpoint - The board of directors of Anhui Liuguo Chemical Co., Ltd. held its second meeting of the ninth session on August 25, 2025, and approved several key resolutions, including the half-year report and asset impairment provisions [1][2]. Group 1: Financial Reporting - The board approved the 2025 half-year report and its summary with unanimous support [1]. - The company conducted a comprehensive review of its assets as of June 30, 2025, resulting in a total credit impairment loss reversal of 4.0029 million and an asset impairment loss provision of 24.7521 million, leading to a total reduction in profit before tax of 20.7492 million [1]. Group 2: Related Party Transactions - The board approved a proposal for a subsidiary to provide counter-guarantees to related parties, with the resolution passed by 6 votes in favor, while related directors abstained from voting [2]. - The board also approved an increase in the expected annual transaction amount with Tongling Huaxing Chemical Co., Ltd. to 130 million, with an estimated total procurement amount of 370 million for the year due to rising sulfur market prices [2]. Group 3: Shareholder Meeting - The board agreed to convene the third extraordinary general meeting of 2025, with details to be disclosed on the Shanghai Stock Exchange website [2].

证券代码：600728 证券简称：佳都科技 公告编号：2025-071 佳都科技集团股份有限公司 关于计提减值准备的公告 佳都科技集团股份有限公司（以下简称"公司"）于2025年8月22日召开了第 十一届董事会第二次会议，审议通过了《关于计提减值准备的议案》，现将具体 情况公告如下： 一、计提资产减值准备情况的说明 为客观、公允地反映公司财务状况和经营成果，根据《企业会计准则》及公 司会计政策的相关规定，公司对截至 2025 年 6 月 30 日的各项资产进行了清查、 分析和评估，对存在减值迹象的资产进行减值测试，按照资产或资产组可收回金 额低于账面价值的金额计提减值准备。 截至 2025 年 6 月 30 日，公司对相关资产计提信用损失准备合计 24,780,496.74 元，计提资产减值准备合计 6,665,649.67 元，明细如下： 单位：元 | （一）信用减值损失 | | | | --- | --- | --- | | 项目 | 本期发生额 | 上期发生额 | | 应收票据坏账损失 | 497,716.08 | -7,904,630.35 | | 应收账款坏账损失 | 23,722,685.20 | ...

《企业会计准则第 22 号 证券代码：600267 证券简称：海正药业 公告编号：临 2025-44 号 浙江海正药业股份有限公司 关于计提资产减值准备的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 浙江海正药业股份有限公司（以下简称"公司"）于 2025 年 8 月 22 日召开 第十届董事会第六次会议和第十届监事会第三次会议，审议通过了《关于计提资 产减值准备的议案》，为了更加客观、公正地反映公司财务状况和资产价值，根 据《企业会计准则》等相关规定，结合企业实际经营情况和资产现状，本着谨慎 性原则，对 2025 年半年度各项资产进行了减值迹象的识别和测试，并根据测试 结果对其中存在减值迹象的资产相应计提资产减值准备，现将具体情况公告如 下： 一、本次计提资产减值准备情况概述 公司根据依照《企业会计准则第 8 号——资产减值》 ——金融工具确认和计量》等相关规定以及公司的实际业务情况，对公司 2025 年半年度合并范围内相关资产进行减值测试，根据测试结果，公司部分资产存在 减值的情形，计提各项资产减值损失 14,24 ...

证券代码：688162 证券简称：巨一科技 公告编号：2025-039 安徽巨一科技股份有限公司 关于 2025 年第二季度计提资产减值准备的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、计提资产减值准备情况概述 根据《企业会计准则》以及安徽巨一科技股份有限公司（以下简称"公司"） 会计政策、会计估计的相关规定，为了真实、准确地反映公司截至 2025 年 6 月 子公司的资产进行了减值测试，对可能发生资产减值损失的相关资产计提减值准 备。 公司 2025 年第二季度确认的资产减值损失和信用减值损失合计为 1,294.75 万元。具体情况如下表所示： 单位：人民币万元 序号 项目 2025年第二季度计提金额 备注 应收票据坏账损失、应收账款坏账损失、 损失 二、计提资产减值准备事项的具体说明 （一） 信用减值损失 本次计提信用减值准备主要为应收票据坏账损失、应收账款坏账损失、应收 款项融资坏账损失和其他应收款坏账损失。在资产负债表日依据公司相关会计政 策和会计估计测算表明其中发生了减值的，公司按规定计提减值准备。 ...

| 证券代码：605138 | | --- | | 证券简称：盛泰集团 | | 公告编号：2025-076 | 转债代码：111009 转债简称：盛泰转债 盛泰智造集团股份有限公司 关于计提资产减值准备的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 盛泰智造集团股份有限公司（以下简称"公司"）根据中国企业会计准则及 公司会计政策的相关规定，基于谨慎性原则对合并报表范围内截至 2025 年 6 月 产相应计提了减值准备，现将相关情况公告如下： 一、资产减值准备情况概述 根据《企业会计准则》及公司会计政策等相关规定，为客观反映公司的财务 状况、经营成果，基于谨慎性原则，公司对截至 2025 年 6 月 30 日公司及下属子 公司的各类资产进行全面评估和减值测试，对可能发生资产减值损失的相关资产 计提减值准备，2025 年半年度计提资产减值损失（含信用减值损失，下同）人 民币 1,979.12 万元，具体如下： | 项目 | 2025 | 年半年度计提减值金额（人民币万元） | | | --- | --- | --- | ...

Core Viewpoint - The board of directors of Black Peony (Group) Co., Ltd. has made several significant resolutions during its 10th session, including asset impairment provisions, financial guarantees, and governance structure changes, reflecting the company's proactive approach to financial management and compliance with regulations [1][2][3]. Group 1: Financial Decisions - The company approved a provision for asset impairment for the first half of 2025, amounting to a reversal of credit impairment provisions of 4.4402 million yuan [2]. - The board agreed to a capital reduction of 280 million yuan for its subsidiary, Changzhou Peony Investment Co., Ltd., reducing its registered capital from 730 million yuan to 450 million yuan [2][3]. - The company and its wholly-owned subsidiary, Changzhou Black Peony Technology Park Co., Ltd., will apply for financing up to 570 million yuan, secured by their own assets [3]. Group 2: Governance Changes - The board resolved to eliminate the supervisory board and transfer its responsibilities to the audit committee, amending the company's articles of association accordingly [4][5]. - Several governance documents, including the rules for shareholder meetings and the prevention of major shareholders and related parties from occupying company funds, were revised to align with the latest legal requirements [5][6][7]. Group 3: Social Responsibility and Donations - The company committed to donating 5 million yuan to the Changzhou Tian Ning District Shuren Education Development Foundation over five years, with an annual contribution of no less than 1 million yuan [4]. Group 4: Upcoming Events - The company has scheduled its first extraordinary general meeting for 2025 on September 10, 2025 [15].

Group 1 - The company held its tenth supervisory board meeting, where the chairman attended via telecommunication due to health reasons, and the meeting complied with relevant laws and regulations [1] - The supervisory board approved the proposal to recognize an asset impairment provision for the first half of 2025, amounting to a reversal of credit loss provisions of 4.4402 million yuan [1][2] - The decision-making process for the asset impairment provision was deemed legal and compliant, reflecting the company's financial status accurately as of June 30, 2025 [2] Group 2 - The supervisory board also approved the 2025 half-year report, confirming that its preparation and review adhered to legal and regulatory requirements, and the report accurately reflects the company's financial condition [2] - The board agreed to abolish the supervisory board and amend the company's articles of association, transferring the supervisory functions to the audit committee of the board of directors [2][3] - The amendments to the articles of association will be submitted for approval at the company's shareholders' meeting [3]

Overview - The company announced the provision for credit impairment and asset impairment for the first half of 2025, totaling RMB 38.75 million, reflecting a cautious approach to financial reporting [1][2]. Credit and Asset Impairment Provision Details - The company conducted impairment testing on assets as of June 30, 2025, resulting in an increase in impairment provisions of RMB 38.75 million and a decrease of RMB 29.61 million [1]. - Breakdown of the provisions includes: - Financing receivables impairment provision increased by RMB 8.73 million and decreased by RMB 9.29 million - Accounts receivable bad debt provision increased by RMB 5.02 million - Other receivables bad debt provision decreased by RMB 0.82 million [1][2]. Impact on Financial Performance - The total impact of the impairment provisions on the company's profit for the period is RMB 9.14 million, which has not been audited by the accounting firm [2]. - The provisions comply with the relevant accounting standards and reflect the company's financial status accurately, ensuring no harm to the interests of shareholders, especially minority shareholders [2][4]. Approval Process - The board of directors and the supervisory board approved the impairment provisions, confirming that the decision-making process adhered to legal regulations and the company's articles of association [3][4]. - The audit committee also supported the provisions, stating they align with accounting policies and reflect the company's financial condition objectively [4].